Danimer Scientific Inc (DNMR) Q2 2024 Earnings Call Highlights: Navigating Revenue Decline and ... — Oct 9th, 2024

Total Revenue: $7.6 million in Q2 2024, down from $12.9 million in the prior year quarter. PHA-based Resin Sales: $5.9 million, a decrease of 30% or $2.5 million year-over-year. PLA-based Resin Sales: $1.4 million, a decrease of $2.4 million compared to the prior year. Gross Loss: $6.9 mil...

Danimer Scientific Inc (DNMR) Q2 2024 Earnings Call Highlights: Navigating Revenue Decline and ... — Oct 9th, 2024

Total Revenue: $7.6 million in Q2 2024, down from $12.9 million in the prior year quarter. PHA-based Resin Sales: $5.9 million, a decrease of 30% or $2.5 million year-over-year. PLA-based Resin Sales: $1.4 million, a decrease of $2.4 million compared to the prior year. Gross Loss: $6.9 mil...

Danimer Scientific Inc (DNMR) Q2 2024 Earnings Call Highlights: Navigating Revenue Decline and ... — Oct 9th, 2024

Total Revenue: $7.6 million in Q2 2024, down from $12.9 million in the prior year quarter. PHA-based Resin Sales: $5.9 million, a decrease of 30% or $2.5 million year-over-year. PLA-based Resin Sales: $1.4 million, a decrease of $2.4 million compared to the prior year. Gross Loss: $6.9 mil...

Danimer Scientific Inc (DNMR) Q2 2024 Earnings Call Highlights: Navigating Revenue Decline and ... — Oct 9th, 2024

Total Revenue: $7.6 million in Q2 2024, down from $12.9 million in the prior year quarter. PHA-based Resin Sales: $5.9 million, a decrease of 30% or $2.5 million year-over-year. PLA-based Resin Sales: $1.4 million, a decrease of $2.4 million compared to the prior year. Gross Loss: $6.9 mil...

Danimer Scientific Inc (DNMR) Q2 2024 Earnings Call Highlights: Navigating Revenue Decline and ... — Oct 9th, 2024

Total Revenue: $7.6 million in Q2 2024, down from $12.9 million in the prior year quarter. PHA-based Resin Sales: $5.9 million, a decrease of 30% or $2.5 million year-over-year. PLA-based Resin Sales: $1.4 million, a decrease of $2.4 million compared to the prior year. Gross Loss: $6.9 mil...

Danimer Scientific Inc (DNMR) Q2 2024 Earnings Call Highlights: Navigating Revenue Decline and ... — Oct 9th, 2024

Total Revenue: $7.6 million in Q2 2024, down from $12.9 million in the prior year quarter. PHA-based Resin Sales: $5.9 million, a decrease of 30% or $2.5 million year-over-year. PLA-based Resin Sales: $1.4 million, a decrease of $2.4 million compared to the prior year. Gross Loss: $6.9 mil...

Danimer Scientific Receives Continued Listing Standard Notice from NYSE — Jan 29th, 2024

The Company’s common stock continues to trade on the NYSE under symbol "DNMR" BAINBRIDGE, Ga., January 29, 2024--(BUSINESS WIRE)--Danimer Scientific, Inc. (NYSE: DNMR) ("Danimer" or the "Company"), a leading, next-generation bioplastics company focused on the production of biodegradable...

Danimer Scientific Inc (DNMR) Q2 2024 Earnings Call Highlights: Navigating Revenue Decline and ... — Oct 9th, 2024

Total Revenue: $7.6 million in Q2 2024, down from $12.9 million in the prior year quarter. PHA-based Resin Sales: $5.9 million, a decrease of 30% or $2.5 million year-over-year. PLA-based Resin Sales: $1.4 million, a decrease of $2.4 million compared to the prior year. Gross Loss: $6.9 mil...

Danimer Scientific Inc (DNMR) Q2 2024 Earnings Call Highlights: Navigating Revenue Decline and ... — Oct 9th, 2024

Total Revenue: $7.6 million in Q2 2024, down from $12.9 million in the prior year quarter. PHA-based Resin Sales: $5.9 million, a decrease of 30% or $2.5 million year-over-year. PLA-based Resin Sales: $1.4 million, a decrease of $2.4 million compared to the prior year. Gross Loss: $6.9 mil...